LRRK2 and Parkinson disease: Interestingly, these mice do not show DAergic neurodegeneration, striatal DA deficits, α-synuclein pathology, or motor deficits, implying that aberrant nuclear architecture might constitute an early characteristic of LRRK2-induced neuronal loss in PD [173] (Table 1).